The FDA has canceled an important March advisory meeting for selecting flu vaccine strains without providing an explanation, amidst growing concerns over vaccination policies and a severe flu season.

The FDA canceled the March meeting of its vaccine advisory panel.

A member of the FDA advisory panel who commented on the canceled meeting.

The current leader of the Department of Health and Human Services, noted for his vaccine skepticism.

The cdc has advisors who make recommendations for vaccines, one of which had a postponed meeting.

Weighing pulling funding for Moderna's bird flu vaccine amid a bird flu outbreak.